Compounded semaglutide and tirzepatide are not the same as FDA-approved products such as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medicines can have a legitimate role for some patients, but they do not undergo the same FDA premarket review for safety, effectiveness, and manufacturing quality as approved medicines.
As of 2026, semaglutide and tirzepatide are no longer listed by FDA as being in shortage, and FDA has increased safety messaging and enforcement around mass-marketed unapproved GLP-1 products.
Why Is FDA Concerned About Compounded GLP-1 Medicines?
FDA has highlighted several potential problems with compounded or unapproved GLP-1 products:
- Dosing errors when patients use multi-dose vials or products with different concentrations.
- Products arriving without appropriate refrigeration or storage.
- Fraudulent labels or online pharmacies that may not be legitimate.
- Use of semaglutide salt forms that are different from the active ingredient in approved products.
- Marketing that makes a compounded product sound equivalent to an FDA-approved medicine.
Are Compounded Semaglutide and Tirzepatide Illegal?
Not automatically. Federal law allows compounding in specific situations, such as when a patient has a clinical need that cannot be met by an available approved product. However, compounders face restrictions on making products that are essentially copies of commercially available medicines. The exact rules depend on the type of compounding pharmacy or facility.
How to Reduce Risk if a Compounded Product Is Prescribed
- Use a licensed healthcare professional and a state-licensed pharmacy.
- Avoid websites that sell injectable weight-loss medicines without a prescription.
- Ask exactly how many milligrams you are prescribed and how that translates to the syringe or device you are using.
- Do not assume that a certain number of “units” equals the same dose across different products.
- Check storage instructions and do not use a product that arrives damaged, improperly stored, or suspiciously labeled.
- Do not switch between compounded and FDA-approved products or change doses without your prescriber.
For an overview of approved treatment options, see our guide to prescription weight-loss medicines.
What About Multi-Dose Vials?
Multi-dose vials can create extra opportunities for measuring mistakes and contamination if handling instructions are not followed carefully. Follow the dispensing pharmacy’s instructions, use the correct syringe, and ask the pharmacist to explain the dose if the label is unclear.
Are These Products “Generic Ozempic”?
No. A compounded product is not an FDA-approved generic version of Ozempic, Wegovy, Zepbound, or Mounjaro. Marketing that uses terms such as “generic Ozempic” can be misleading.
When to Get Medical Help
Seek medical advice promptly for severe or persistent vomiting, severe abdominal pain, dehydration, fainting, or symptoms of low blood sugar, especially if you also use insulin or a sulfonylurea. If you suspect a dosing mistake, contact your prescriber, pharmacist, poison center, or emergency service as appropriate.
Planning for Long-Term GLP-1 Treatment
Compounded or approved GLP-1 medicines should be part of a clinician-guided treatment plan rather than treated as short-term cosmetic products. If you are considering stopping therapy, our guide to weight regain after GLP-1 medicines explains why regain can occur and why treatment changes should be planned with a prescriber.
If you are also considering vitamins, protein powders, or other products while using a GLP-1 medicine, see our evidence-based guide to GLP-1 medicines and supplements.
Frequently Asked Questions
Are compounded GLP-1 medicines FDA-approved?
No. Compounded medicines are not FDA-approved, even when they contain semaglutide or tirzepatide.
Can a compounded GLP-1 product be appropriate for some patients?
Yes, in certain circumstances a clinician may determine that a compounded medicine is appropriate, but this should be based on an individual medical need and a legitimate prescription.
Should I switch from an approved product to a compounded version to save money?
Do not switch products on your own. Differences in concentration, instructions, storage, and product quality can create safety risks.
Bottom Line
Compounded semaglutide and tirzepatide may have a legitimate role for selected patients, but they are not FDA-approved substitutes and are not approved generics. Use them only through licensed healthcare professionals and pharmacies, with clear dosing and storage instructions.
Reliable Sources
Last reviewed for medical accuracy: September 2026.